Your browser doesn't support javascript.
loading
[Application strategies of the third-generation EGFR-TKI in the context of precision medicine].
Zhao, J; Zhang, S J; Zhou, C C.
Affiliation
  • Zhao J; Department of Medical Oncology, Shanghai Pulmomary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
  • Zhang SJ; Department of Medical Oncology, Shanghai Pulmomary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
  • Zhou CC; Department of Medical Oncology, Shanghai Pulmomary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
Zhonghua Zhong Liu Za Zhi ; 39(2): 86-89, 2017 Feb 23.
Article in Zh | MEDLINE | ID: mdl-28219200
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Precision Medicine / ErbB Receptors / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2017 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Precision Medicine / ErbB Receptors / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2017 Document type: Article Affiliation country: China Country of publication: China